JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

Home・Akciju saraksts・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Slēgts

2.21 -1.78

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.05

Max

2.25

Galvenie mērījumi
By Trading Economics
Ienākumi	1.1M -16M
Pārdošana	2.8M 50M
Peļņas marža	-32.437
Darbinieki	477
EBITDA	1.3M -12M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+132.3% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 26. febr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-272M 144M
Iepriekšējā atvēršanas cena	3.99
Iepriekšējā slēgšanas cena	2.21

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

7.16 / 7.65 Atbalsts un pretestība

Treace Medical Concepts Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 9. febr. 17:25 UTC

Iegādes, apvienošanās, pārņemšana

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

2026. g. 9. febr. 23:46 UTC

Tirgus saruna

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

2026. g. 9. febr. 23:43 UTC

Tirgus saruna

Gold Falls on Possible Technical Correction -- Market Talk

2026. g. 9. febr. 23:14 UTC

Tirgus saruna

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

2026. g. 9. febr. 22:29 UTC

Tirgus saruna

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

2026. g. 9. febr. 22:19 UTC

Tirgus saruna

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

2026. g. 9. febr. 22:08 UTC

Tirgus saruna

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

2026. g. 9. febr. 22:01 UTC

Peļņas

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

2026. g. 9. febr. 21:59 UTC

Peļņas

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

2026. g. 9. febr. 21:59 UTC

Peļņas

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

2026. g. 9. febr. 21:58 UTC

Peļņas

Friedman Industries 3Q Sales $168M >FRD

2026. g. 9. febr. 21:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Financial Services Roundup: Market Talk

2026. g. 9. febr. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 9. febr. 21:48 UTC

Peļņas

Friedman Industries 3Q EPS 43c >FRD

2026. g. 9. febr. 21:17 UTC

Peļņas

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

2026. g. 9. febr. 21:13 UTC

Tirgus saruna

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

2026. g. 9. febr. 21:04 UTC

Peļņas

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

2026. g. 9. febr. 20:30 UTC

Tirgus saruna

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

2026. g. 9. febr. 20:02 UTC

Tirgus saruna

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

2026. g. 9. febr. 19:42 UTC

Tirgus saruna

Japan's Yield Curve Expected to Flatten -- Market Talk

2026. g. 9. febr. 19:31 UTC

Tirgus saruna

Nike Seen Regaining Relevance With Consumers -- Market Talk

2026. g. 9. febr. 19:27 UTC

Tirgus saruna

Gold Climbs Back Over $5,000/oz -- Market Talk

2026. g. 9. febr. 19:05 UTC

Tirgus saruna

Nike Returns to List of Hottest Brands -- Market Talk

2026. g. 9. febr. 18:19 UTC

Tirgus saruna

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

2026. g. 9. febr. 17:41 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

2026. g. 9. febr. 17:31 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

2026. g. 9. febr. 17:20 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Financial Services Roundup: Market Talk

2026. g. 9. febr. 17:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 9. febr. 17:17 UTC

Tirgus saruna

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

2026. g. 9. febr. 17:16 UTC

Peļņas

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Treace Medical Concepts Inc Prognoze

Cenas mērķis

By TipRanks

132.3% augšup

Prognoze 12 mēnešiem

Vidējais 5.25 USD 132.3%

Augstākais 7.5 USD

Zemākais 3 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

7.16 / 7.65Atbalsts un pretestība

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.